BioMaxima S.A.
BMX.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 45 | PLN 71 | PLN 111 | PLN 114 |
| - Cash | PLN 1 | PLN 2 | PLN 13 | PLN 0 |
| + Debt | PLN 15 | PLN 13 | PLN 6 | PLN 17 |
| Enterprise Value | PLN 59 | PLN 82 | PLN 104 | PLN 131 |
| Revenue | PLN 53 | PLN 47 | PLN 144 | PLN 79 |
| % Growth | 13% | -67.5% | 81.9% | – |
| Gross Profit | PLN 23 | PLN 20 | PLN 54 | PLN 29 |
| % Margin | 44% | 42.8% | 37.7% | 36.7% |
| EBITDA | PLN 5 | PLN 3 | PLN 38 | PLN 15 |
| % Margin | 8.8% | 7% | 26.7% | 18.7% |
| Net Income | PLN 1 | PLN 1 | PLN 29 | PLN 10 |
| % Margin | 1% | 1.3% | 20.1% | 13% |
| EPS Diluted | 0.13 | 0.14 | 6.48 | 2.29 |
| % Growth | -7.1% | -97.8% | 183% | – |
| Operating Cash Flow | -PLN 0 | PLN 2 | PLN 37 | -PLN 0 |
| Capital Expenditures | -PLN 2 | -PLN 18 | -PLN 10 | -PLN 4 |
| Free Cash Flow | -PLN 2 | -PLN 16 | PLN 27 | -PLN 5 |